Childhood Medulloepithelioma Terminated Phase 1 Trials for RG-4733 (DB11870)

IndicationStatusPhase
DBCOND0030159 (Childhood Medulloepithelioma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01088763Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTreatment